El interés en corto de Corsair Gaming da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de Corsair Gaming. Los datos de interés en corto se actualizan cada dos semanas.

Corsair Gaming (NASDAQ:CRSR) Bolsa, Informe de interés en corto

Corsair Gaming

Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue-generating segment; and Gaming Components and Systems. Geographically, the group derives revenue from the Americas, Europe and the Middle East, and the Asia Pacific.

Corsair Gaming Inc

Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) is looking for Q2 Adj EPS of $1.30-$1.50 vs $1.41 analyst estimate..

News

Guidance

Celanese Sees Q2 Adj EPS $1.30-$1.50 vs $1.41 Est

BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) affirms FY2025 sales outlook from $2.26 billion-$2.34 billion to $2.26 billion-$2.34 billion vs $2.32 billion estimate.

BRBR

BellRing Brands Affirms FY2025 Sales Guidance of $2.26B-$2.34B vs $2.32B Est

Granite Point Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPMT#NYSE">GPMT</a>) is preparing to release its quarterly earnings on Tuesday, 2025-05-06. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Granite Point Mortgage to report an earnings per share (EPS) of $-0.67.
Granite Point Mortgage bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Earnings Track Record</h3>
Last quarter the company missed EPS by $0.67, which was followed by a 9.09% drop in the share price the next day.
Here's a look at Granite Point Mortgage's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-1.31</td>
<td>-0.82</td>
<td>-0.21</td>
<td>0.02</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-1.98</td>
<td>-0.75</td>
<td>-0.05</td>
<td>0.03</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-9.0%</td>
<td>1.0%</td>
<td>-4.0%</td>
<td>-13.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746478918_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Granite Point Mortgage were trading at $1.95 as of May 02. Over the last 52-week period, shares are down 56.39%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/GPMT/earnings">To track all earnings releases for Granite Point Mortgage visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

GPMT

A Look at Granite Point Mortgage's Upcoming Earnings Report

UBS analyst Dennis Geiger maintains Papa John's International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PZZA#NASDAQ">PZZA</a>) with a Neutral and lowers the price target from $45 to $38.

Price Target

Analyst Ratings

PZZA

UBS Maintains Neutral on Papa John's International, Lowers Price Target to $38

Cipher Mining (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) is gearing up to announce its quarterly earnings on Tuesday, 2025-05-06. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Cipher Mining will report an earnings per share (EPS) of $0.06.
Investors in Cipher Mining are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Overview of Past Earnings</h3>
The company's EPS beat by $0.09 in the last quarter, leading to a 1.83% increase in the share price on the following day.
Here's a look at Cipher Mining's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.05</td>
<td>-0.08</td>
<td>-0.03</td>
<td>0.01</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.14</td>
<td>-0.01</td>
<td>-0.01</td>
<td>0.13</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>6.0%</td>
<td>-7.000000000000001%</td>
<td>-0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746478897_0.png" alt="eps graph" />
<h3>Cipher Mining Share Price Analysis</h3>
Shares of Cipher Mining were trading at $3.16 as of May 02. Over the last 52-week period, shares are down 21.37%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<h3>Analyst Views on Cipher Mining</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Cipher Mining.
Analysts have provided Cipher Mining with 5 ratings, resulting in a consensus rating of Buy. The average one-year price target stands at $7.9, suggesting a potential 150.0% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
The analysis below examines the analyst ratings and average 1-year price targets of Verint Systems, Quantum Computing and Amplitude, three significant industry players, providing valuable insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Verint Systems, with an average 1-year price target of $28.4, suggesting a potential 798.73% upside.</li>
<li>Analysts currently favor an Buy trajectory for Quantum Computing, with an average 1-year price target of $14.0, suggesting a potential 343.04% upside.</li>
<li>Analysts currently favor an Buy trajectory for Amplitude, with an average 1-year price target of $14.53, suggesting a potential 359.81% upside.</li>
</ul>
<h3>Analysis Summary for Peers</h3>
Within the peer analysis summary, vital metrics for Verint Systems, Quantum Computing and Amplitude are presented, shedding light on their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Cipher Mining</td>
<td>Buy</td>
<td>-2.75%</td>
<td>$7.29M</td>
<td>2.59%</td>
</tr>
<tr>
<td>Verint Systems</td>
<td>Buy</td>
<td>-4.36%</td>
<td>$186.48M</td>
<td>3.26%</td>
</tr>
<tr>
<td>Quantum Computing</td>
<td>Buy</td>
<td>-17.33%</td>
<td>$34K</td>
<td>-61.10%</td>
</tr>
<tr>
<td>Amplitude</td>
<td>Buy</td>
<td>9.42%</td>
<td>$58.33M</td>
<td>-11.11%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Cipher Mining ranks at the bottom for Revenue Growth, with a negative growth rate. It also ranks at the bottom for Gross Profit, with the lowest amount among peers. However, it ranks in the middle for Return on Equity, indicating moderate performance in this aspect. Overall, Cipher Mining's performance is weaker compared to its peers in terms of revenue growth and gross profit.
<h3>All You Need to Know About Cipher Mining</h3>
Cipher Mining Inc ia an emerging technology company that operates in the Bitcoin mining ecosystem in the United States. The company is developing a cryptocurrency mining business, specializing in Bitcoin. The company is expanding and strengthening the Bitcoin network's critical infrastructure in the United States.
<h3>Cipher Mining: A Financial Overview</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Negative Revenue Trend: Examining Cipher Mining's financials over 3 months reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -2.75% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: Cipher Mining's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 41.47%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Cipher Mining's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.59%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Cipher Mining's ROA excels beyond industry benchmarks, reaching 2.15%. This signifies efficient management of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.08, Cipher Mining adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/CIFR/earnings">To track all earnings releases for Cipher Mining visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CIFR

Insights Ahead: Cipher Mining's Quarterly Earnings

BellRing Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRBR#NYSE">BRBR</a>) reported quarterly earnings of $0.53 per share which beat the analyst consensus estimate of $0.52 by 1.92 percent. This is a 17.78 percent increase over earnings of $0.45 per share from the same period last year. The company reported quarterly sales of $588.00 million which beat the analyst consensus estimate of $578.37 million by 1.67 percent. This is a 18.88 percent increase over sales of $494.60 million the same period last year.

Earnings Beats

BellRing Brands Q2 Adj. EPS $0.53 Beats $0.52 Estimate, Sales $588.00M Beat $578.37M Estimate

Over multiple decades, legendary investor Warren Buffett has helped produce incredible returns for conglomerate Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>), often times <a href="https://www.benzinga.com/general/education/25/01/42832123/warren-buffett-beats-sp-500-in-2024-how-oracle-of-omahas-returns-compare-over-past-20-years">outperforming the S&amp;P 500.</a>
With news that Buffett <a href="https://www.benzinga.com/25/05/45184410/warren-buffett-to-step-down-as-berkshire-hathaway-ceo-by-end-of-year-asks-board-to-confirm-greg-abel-as-successor">is stepping down</a> as Berkshire CEO at the end of the year, here's a look at the top 10 stock holdings of the Berkshire Hathaway portfolio.
Buffett Builds Berkshire Hathaway: Buffett has shaped Berkshire Hathaway from the <a href="https://www.benzinga.com/general/education/24/08/40652464/warren-buffett-celebrates-94th-birthday-with-1-trillion-market-cap-milestone-a-look-back-at-hig">early days of a textile maker </a>into a conglomerate that owns companies like Duracell, Dairy Queen, GEICO, Fruit of the Loom, Jazwares, Pilot Flying J and more.
Along with acquiring businesses outright, Buffett has also built a portfolio of large stakes in publicly traded companies over the years.
Here's a look at the current top 10 holdings of Berkshire Hathaway's stock portfolio, as reported by <a href="https://www.cnbc.com/berkshire-hathaway-portfolio/">CNBC</a>. The list includes the stock, the current value and percentage of the stock portfolio.
<ol>
<li>Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>): $60.1 billion, 21.8% of the portfolio</li>
<li>American Express (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXP#NYSE">AXP</a>): $42.4 billion, 15.4%</li>
<li>Coca-Cola Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>): $28.7 billion, 10.4%</li>
<li>Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>): $28.2 billion, 10.2%</li>
<li>Chevron Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>): $16.1 billion, 5.8%</li>
<li>Moody's Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>): $11.5 billion, 4.2%</li>
<li>Occidental Petroleum Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>): $10.4 billion, 3.8%</li>
<li>Kraft Heinz Co (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>): $9.3 billion, 3.4%</li>
<li>Chubb Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>): $7.8 billion, 2.8%</li>
<li>Itochu Corporation: $7.1 billion, 2.6%</li>
</ol>
Together, the top 10 stocks in the Berkshire Hathaway represent 80.4% of the portfolio. Berkshire Hathaway owns stakes of 6% or more in each of the 10 companies, other than Apple. Berkshire owns around 2% of Apple.
Many of these stocks have been long-time holdings of Berkshire Hathaway added decades ago. Others, like Apple, have been added to the portfolio as Buffett's opinion on a stock or sector change.
Read Also: <a href="https://www.benzinga.com/news/management/25/05/45176283/warren-buffett-is-getting-richer-in-2025-and-its-not-because-of-apple-how-one-chinese-holding-is-helping">Warren Buffett Is Getting Richer In 2025 — And It&#8217;s Not Because Of Apple: How One Chinese Holding Is Helping</a>
Berkshire Hathaway Performance: Shares of Berkshire Hathaway hit new all-time highs on Friday ahead of the annual shareholders meeting, where Buffett surprised the crowd with his stepping down announcement.
On Monday, Berkshire Hathaway stock fell over 5% as investors grasped what the company could look like without Buffett and with the company reporting lower operating profit year-over-year.
Year-to-date, Berkshire Hathaway stock is up 13.2%, outperforming the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), which is down 3.4%. Berkshire Hathaway has also outperformed the S&amp;P 500 ETF over the one-year and five-year periods.
Here's a look at the year-to-date performance of the top 10 Berkshire Hathaway holdings:
<ol>
<li>Apple: -18.2%</li>
<li>American Express: -6.5%</li>
<li>Coca-Cola Co: +15.8%</li>
<li>Bank of America: -6.8%</li>
<li>Chevron Corp: -7.7%</li>
<li>Moody's Corp: -1.7%</li>
<li>Occidental Petroleum: -21.7%</li>
<li>Kraft Heinz: -7.4%</li>
<li>Chubb Ltd: +5.7%</li>
<li>Itochu: -9.7%</li>
</ol>
Of the top 10 holdings, only two are positive year-to-date in 2025, putting more pressure on the Berkshire Hathaway non-stock holdings like the insurance and energy units, which are wholly owned, to perform well during the year.
With a changing of CEO, there is a chance that the top 10 holdings in the Berkshire Hathaway stock portfolio look significantly different at this time next year. Although, many of these stocks have been outperforming the market and helping Berkshire Hathaway produce strong returns annually.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/04/44928468/warren-buffett-believer-in-american-companies-critical-of-tariffs-the-tooth-fairy-doesnt-pay-em">Warren Buffett, Believer In American Companies, Is Critical Of Tariffs: &#8216;The Tooth Fairy Doesn&#8217;t Pay &#8216;Em&#8217;</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Education

Trading Ideas

AAPL

Warren Buffett's Giant Berkshire Portfolio: Top 10 Includes Banks, Oil, And Apple

Ratings for Arvinas (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARVN#NASDAQ">ARVN</a>) were provided by 25 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">10</td>
<td align="right">8</td>
<td align="right">7</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $31.52, along with a high estimate of $82.00 and a low estimate of $8.00. A 37.31% drop is evident in the current average compared to the previous average price target of $50.28. 
<img src="https://www.benzinga.com/files/images/story/2025/1746478862_0.png" alt="price target chart" />
<h2>Understanding Analyst Ratings: A Comprehensive Breakdown</h2>
The standing of Arvinas among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Srikripa Devarakonda</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$11.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Evan David Seigerman</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$10.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Derek Archila</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Paul Choi</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$8.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Michael Schmidt</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$16.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Edward Tenthoff</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$14.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Peter Lawson</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Lowers</td>
<td>Buy</td>
<td>$24.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Akash Tewari</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$10.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Paul Choi</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$12.00</td>
<td>$15.00</td>
</tr>
<tr>
<td>Joon Lee</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$21.00</td>
<td>$65.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$81.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$81.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Terence Flynn</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$12.00</td>
<td>$48.00</td>
</tr>
<tr>
<td>Michael Schmidt</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$32.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Derek Archila</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$26.00</td>
<td>$60.00</td>
</tr>
<tr>
<td>Etzer Darout</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$20.00</td>
<td>$82.00</td>
</tr>
<tr>
<td>Robert Driscoll</td>
<td>Wedbush</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$12.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Tazeen Ahmad</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$28.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Andrew Fein</td>
<td>HC Wainwright &amp; Co.</td>
<td>Maintains</td>
<td>Buy</td>
<td>$81.00</td>
<td>$81.00</td>
</tr>
<tr>
<td>Yigal Nochomovitz</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$19.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Matthew Biegler</td>
<td>Oppenheimer</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Etzer Darout</td>
<td>BMO Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$82.00</td>
<td>$88.00</td>
</tr>
<tr>
<td>Michael Schmidt</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$57.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Bradley Canino</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$51.00</td>
<td>$63.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Arvinas. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Arvinas compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Arvinas's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Arvinas's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/ARVN/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Arvinas analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Arvinas</h2>
Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.
<h3>A Deep Dive into Arvinas's Financials</h3>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
Revenue Growth: Arvinas displayed positive results in 3M. As of 31 March, 2025, the company achieved a solid revenue growth rate of approximately 646.25%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Health Care sector.
Net Margin: Arvinas's net margin is impressive, surpassing industry averages. With a net margin of 43.91%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 13.57%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Arvinas's ROA excels beyond industry benchmarks, reaching 7.92%. This signifies efficient management of assets and strong financial health.
Debt Management: Arvinas's debt-to-equity ratio is below the industry average at 0.02, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARVN

Where Arvinas Stands With Analysts

EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) underwent analysis by 18 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">8</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">5</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for EQT, revealing an average target of $56.67, a high estimate of $67.00, and a low estimate of $35.00. Surpassing the previous average price target of $52.83, the current average has increased by 7.27%.
<img src="https://www.benzinga.com/files/images/story/2025/1746478853_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A clear picture of EQT's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$64.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Devin McDermott</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$65.00</td>
<td>$62.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$35.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$54.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$57.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>David Deckelbaum</td>
<td>TD Cowen</td>
<td>Maintains</td>
<td>Buy</td>
<td>$54.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$55.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Nitin Kumar</td>
<td>Mizuho</td>
<td>Raises</td>
<td>Outperform</td>
<td>$60.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Devin McDermott</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$67.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Roger Read</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$58.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Mike Scialla</td>
<td>Stephens &amp; Co.</td>
<td>Raises</td>
<td>Overweight</td>
<td>$59.00</td>
<td>$41.00</td>
</tr>
<tr>
<td>Scott Gruber</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$60.00</td>
<td>$51.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$58.00</td>
</tr>
<tr>
<td>Mark Lear</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$36.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$58.00</td>
<td>$54.00</td>
</tr>
<tr>
<td>Arun Jayaram</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$58.00</td>
<td>$53.00</td>
</tr>
<tr>
<td>Josh Silverstein</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$54.00</td>
<td>$49.00</td>
</tr>
<tr>
<td>Umang Choudhary</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$66.00</td>
<td>$59.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to EQT. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of EQT compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of EQT's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of EQT's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/EQT/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on EQT analyst ratings.</a>
<h2>Discovering EQT: A Closer Look</h2>
EQT is an independent natural gas production company. It focuses its operations in the cores of the Marcellus and Utica shales, located in the Appalachian Basin in the Eastern United States. Its main customers include marketers, utilities, and industrial operators in the Appalachian Basin. The company has three reportable segments in production, gathering, and its transmission segment, which is now an operated joint venture with Blackstone. All the firm's operating revenue is generated in the US, with most revenue flowing from the Marcellus Shale field and through the sale of natural gas.
<h3>Financial Milestones: EQT's Journey</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Revenue Growth: EQT's remarkable performance in 3M is evident. As of 31 March, 2025, the company achieved an impressive revenue growth rate of 85.24%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Energy sector.
Net Margin: EQT's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 10.01%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 1.17%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): EQT's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of 0.61%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: EQT's debt-to-equity ratio is below the industry average at 0.41, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Demystifying EQT: Insights From 18 Analyst Reviews

Ratings for United States Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $42.0, a high estimate of $45.00, and a low estimate of $38.00. Witnessing a positive shift, the current average has risen by 4.14% from the previous average price target of $40.33.
<img src="https://www.benzinga.com/files/images/story/2025/1746478839_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive United States Steel is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Carlos De Alba</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$38.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Bill Peterson</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$38.00</td>
<td>$43.00</td>
</tr>
<tr>
<td>Katja Jancic</td>
<td>BMO Capital</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$45.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Katja Jancic</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$45.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Bill Peterson</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$43.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Carlos De Alba</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$43.00</td>
<td>$39.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to United States Steel. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of United States Steel compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of United States Steel's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Capture valuable insights into United States Steel's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/X/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on United States Steel analyst ratings.</a>
<h2>About United States Steel</h2>
United States Steel Corp operates in the United States but also has a steelmaking capacity in Slovakia. The company's operating segments include North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment includes U. S. Steel's integrated steel plants and equity investees in North America involved in the production of slabs, strip mill plates, sheets, and tin mill products, as well as all iron ore and coke production facilities in the United States. It serves North American customers in the service center, conversion, transportation, construction, container, and appliance, and electrical markets.
<h3>United States Steel's Financial Performance</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Decline in Revenue: Over the 3M period, United States Steel faced challenges, resulting in a decline of approximately -15.32% in revenue growth as of 31 December, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Materials sector.
Net Margin: United States Steel's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -2.54%, the company may face hurdles in effective cost management.
Return on Equity (ROE): United States Steel's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -0.78%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of -0.44%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.37, United States Steel adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: Simplified</h2>
Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Deep Dive Into United States Steel Stock: Analyst Perspectives (6 Ratings)

In the preceding three months, 6 analysts have released ratings for Birkenstock Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BIRK#NYSE">BIRK</a>), presenting a wide array of perspectives from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $67.33, a high estimate of $72.00, and a low estimate of $60.00. This current average represents a 3.36% decrease from the previous average price target of $69.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1746478831_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Birkenstock Holding is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jay Sole</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$72.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Anna Andreeva</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$60.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Jim Duffy</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$62.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
<tr>
<td>Dana Telsey</td>
<td>Telsey Advisory Group</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$70.00</td>
<td>$70.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Birkenstock Holding. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Birkenstock Holding compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Birkenstock Holding's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
For valuable insights into Birkenstock Holding's market performance, consider these analyst evaluations alongside crucial financial indicators. Stay well-informed and make prudent decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BIRK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Birkenstock Holding analyst ratings.</a>
<h2>Get to Know Birkenstock Holding Better</h2>
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).
<h3>Birkenstock Holding: Delving into Financials</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Birkenstock Holding's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 19.41%. This indicates a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Consumer Discretionary sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of 5.56%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Birkenstock Holding's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 0.75%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): The company's ROA is below industry benchmarks, signaling potential difficulties in efficiently utilizing assets. With an ROA of 0.41%, the company may need to address challenges in generating satisfactory returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.51, Birkenstock Holding adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BIRK

Beyond The Numbers: 6 Analysts Discuss Birkenstock Holding Stock

UBS analyst Dennis Geiger maintains Restaurant Brands Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QSR#NYSE">QSR</a>) with a Buy and lowers the price target from $90 to $85.

UBS Maintains Buy on Restaurant Brands Intl, Lowers Price Target to $85

During the last three months, 13 analysts shared their evaluations of Bloom Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BE#NYSE">BE</a>), revealing diverse outlooks from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">7</td>
<td align="right">4</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for Bloom Energy, revealing an average target of $24.77, a high estimate of $35.00, and a low estimate of $10.00. This current average has decreased by 10.61% from the previous average price target of $27.71. 
<img src="https://www.benzinga.com/files/images/story/2025/1746478824_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Bloom Energy among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Maheep Mandloi</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$26.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Kashy Harrison</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$26.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Stephen Byrd</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$30.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Jordan Levy</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Hold</td>
<td>$19.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Lloyd Byrne</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Hold</td>
<td>$19.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Chip Moore</td>
<td>Roth MKM</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$26.00</td>
</tr>
<tr>
<td>Ben Kallo</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$27.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Biju Perincheril</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$26.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Skye Landon</td>
<td>Redburn Atlantic</td>
<td>Lowers</td>
<td>Sell</td>
<td>$10.00</td>
<td>$14.50</td>
</tr>
<tr>
<td>Samantha Hoh</td>
<td>HSBC</td>
<td>Maintains</td>
<td>Buy</td>
<td>$25.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Stephen Byrd</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$35.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Maheep Mandloi</td>
<td>Mizuho</td>
<td>Announces</td>
<td>Neutral</td>
<td>$28.00</td>
<td>-</td>
</tr>
<tr>
<td>Kashy Harrison</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$31.00</td>
<td>$33.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Bloom Energy. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Bloom Energy compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Bloom Energy's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Bloom Energy's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/BE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Bloom Energy analyst ratings.</a>
<h2>About Bloom Energy</h2>
Bloom Energy designs, manufactures, sells, and installs solid-oxide fuel cell systems ("Energy Servers") for on-site power generation. Bloom Energy Servers are fuel-flexible and can use natural gas, biogas, and hydrogen to create 24/7 electricity for stationary applications. In 2021, the company announced plans to leverage its technology and enter the electrolyzer market. Bloom primarily sells its systems in the United States and internationally.
<h3>Bloom Energy's Economic Impact: An Analysis</h3>
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Over the 3M period, Bloom Energy showcased positive performance, achieving a revenue growth rate of 38.56% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: Bloom Energy's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -7.3%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Bloom Energy's ROE stands out, surpassing industry averages. With an impressive ROE of -4.18%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Bloom Energy's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -0.9% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 2.63, caution is advised due to increased financial risk.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Expert Outlook: Bloom Energy Through The Eyes Of 13 Analysts

In the current session, the stock is trading at $25.61, after a 0.23% spike. Over the past month, Intl General Insurance Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IGIC#NASDAQ">IGIC</a>) stock increased by 16.41%, and in the past year, by 91.70%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1746478819_0.png" alt="Past Year Chart" />

<h3>Intl General Insurance P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Intl General Insurance has a lower P/E than the aggregate P/E of 18.8 of the Insurance industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1746478819_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

IGIC

A Look Into Intl General Insurance Inc's Price Over Earnings

Throughout the last three months, 12 analysts have evaluated Mohawk Industries (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MHK#NYSE">MHK</a>), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $136.75, a high estimate of $165.00, and a low estimate of $105.00. This current average has decreased by 7.45% from the previous average price target of $147.75. 
<img src="https://www.benzinga.com/files/images/story/2025/1746478814_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Mohawk Industries among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Matthew Bouley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$111.00</td>
<td>$115.00</td>
</tr>
<tr>
<td>Mike Dahl</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$119.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Sam Reid</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$105.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Matthew Bouley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$115.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Sam Darkatsh</td>
<td>Raymond James</td>
<td>Lowers</td>
<td>Strong Buy</td>
<td>$165.00</td>
<td>$185.00</td>
</tr>
<tr>
<td>Laura Champine</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Buy</td>
<td>$155.00</td>
<td>$180.00</td>
</tr>
<tr>
<td>Michael Rehaut</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$156.00</td>
<td>$161.00</td>
</tr>
<tr>
<td>Stephen Kim</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>In-Line</td>
<td>$140.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Keith Hughes</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$148.00</td>
<td>$155.00</td>
</tr>
<tr>
<td>Matthew Bouley</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$125.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Timothy Wojs</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$152.00</td>
<td>$160.00</td>
</tr>
<tr>
<td>Rafe Jadrosich</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$150.00</td>
<td>$152.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Mohawk Industries. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Mohawk Industries compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Mohawk Industries's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Mohawk Industries's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/MHK/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Mohawk Industries analyst ratings.</a>
<h2>Unveiling the Story Behind Mohawk Industries</h2>
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
<h3>Unraveling the Financial Story of Mohawk Industries</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Negative Revenue Trend: Examining Mohawk Industries's financials over 3M reveals challenges. As of 31 March, 2025, the company experienced a decline of approximately -4.22% in revenue growth, reflecting a decrease in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Discretionary sector.
Net Margin: Mohawk Industries's net margin is impressive, surpassing industry averages. With a net margin of 2.87%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Mohawk Industries's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 0.94% ROE, the company effectively utilizes shareholder equity capital.
Return on Assets (ROA): Mohawk Industries's ROA excels beyond industry benchmarks, reaching 0.55%. This signifies efficient management of assets and strong financial health.
Debt Management: Mohawk Industries's debt-to-equity ratio is below the industry average. With a ratio of 0.35, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Basics of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Mohawk Industries Stock

Vertex Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) reported first-quarter financial results after the market close on Monday. Here&#8217;s a look at the key highlights <a href="https://www.benzinga.com/pressreleases/25/05/b45206073/vertex-reports-first-quarter-2025-financial-results">from the period</a>.
<ul>
<li>Q1 Revenue: $2.77 billion versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $2.85 billion</li>
</ul>
<ul>
<li>Q1 EPS: $4.06, versus estimates of $4.32</li>
</ul>
Total revenue grew 3% year-over-year in the first quarter, driven primarily by the continued performance of TRIKAFTA, KAFTRIO&nbsp;and an early contribution from the U.S. launch of ALYFTREK. 
Revenue climbed 9% year-over-year in the U.S., but fell 5% year-over-year outside the U.S. The company noted that the international decline was expected, citing a &#8220;violation of its intellectual property rights&#8221; in Russia that is expected to be a &#8220;limited and isolated matter.&#8221;
&#8220;Vertex delivered a strong start to 2025 with notable execution across the business as we grow and diversify the revenue base, progress multiple launches and advance the R&amp;D pipeline,&#8221; said Reshma Kewalramani, president and CEO of Vertex.&nbsp;
&#8220;With multiple programs in pivotal development including povetacicept, which continues to make rapid progress in achieving its potential as a pipeline-in-a-product, and additional programs in early and mid-stage development, Vertex is poised to continue to deliver value for years to come.&#8221;
Vertex ended the quarter with $11.4 billion in cash, cash equivalents and marketable securities, up from $11.2 billion at the end of 2024.
Guidance: Vertex Pharmaceuticals raised its full-year 2025 revenue guidance from a range of $11.75 billion to $12 billion to a new range of $11.85 billion to $12 billion versus estimates of $11.97 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Vertex executives are currently discussing details from the quarter on a call with investors and analysts that started at 4:30 p.m. ET.
VRTX Price Action:<a href="http://benzinga.com/quote/vrtx"> Vertex Pharmaceuticals shares</a> were down 3.04% after-hours, trading at $485 at the time of publication on Monday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/biotech/25/05/45207987/tg-therapeutics-falls-short-on-earnings-but-briumvi-sales-steal-the-show">TG Therapeutics Falls Short On Earnings, But Briumvi Sales Steal the Show</a></li>
</ul>
Photo: Courtesy of Vertex Pharmaceuticals.

Biotech

Health Care

Movers

VRTX

Vertex Pharmaceuticals Stock Falls On Q1 Earnings, Revenue Miss — Company Raises Low End Of FY25 Revenue Guidance

UBS analyst Dennis Geiger maintains Sweetgreen (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SG#NYSE">SG</a>) with a Buy and lowers the price target from $35 to $30.

UBS Maintains Buy on Sweetgreen, Lowers Price Target to $30

Celanese (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CE#NYSE">CE</a>) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.38 by 50 percent. This is a 72.6 percent decrease over earnings of $2.08 per share from the same period last year. The company reported quarterly sales of $2.39 billion which beat the analyst consensus estimate of $2.25 billion by 5.98 percent. This is a 8.50 percent decrease over sales of $2.61 billion the same period last year.

Celanese Q1 Adj. EPS $0.57 Beats $0.38 Estimate, Sales $2.39B Beat $2.25B Estimate

UBS analyst Timothy Arcuri maintains Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) with a Buy and lowers the price target from $60 to $55.

SMTC

UBS Maintains Buy on Semtech, Lowers Price Target to $55

Needham analyst Laura Martin maintained FuboTV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) with a Buy and lowered the <a href="https://www.benzinga.com/quote/FUBO/analyst-ratings" target="_blank" rel="noreferrer noopener">price target from $3.35 to $3</a> on Monday.
Last Friday, FuboTV reported <a href="https://www.benzinga.com/news/earnings/25/05/45165703/fubotv-stock-drops-after-q1-subscriber-losses-and-lower-than-expected-outlook" target="_blank" rel="noreferrer noopener">first-quarter growth</a> of 8.1% year over year to $405.96 million, marginally missing the analyst consensus estimate of $415.45 million. Adjusted EPS loss of two cents beat the analyst consensus estimate of nine cents.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45165703/fubotv-stock-drops-after-q1-subscriber-losses-and-lower-than-expected-outlook" rel="noreferrer noopener">FuboTV Stock Drops After Q1 Subscriber Losses And Lower-Than-Expected Outlook</a>
FuboTV reiterated plans to launch a new skinny bundle before the fall 2025 NFL season, including content from Walt Disney Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) and non-Disney linear TV programmers.
These bundles should represent more choices and lower content costs for FuboTV.
FuboTV stated that the Disney deal is still on track to close by the second quarter of 2026.
The company also noted that higher churn is not seen on English-language packages, which were flat to up Y/Y, even after its price hikes.
Also, reactivations exceeded expectations in April, and ad trends improved, with April marking the strongest ad revenue month year-to-date.
FuboTV reported revenue of $416.3 million (up 3% Y/Y and 1% above Martin&#8217;s estimates) and an adjusted EBITDA Loss of $1.4 million (better by 96% Y/Y and 58% better than Martin&#8217;s estimate).
First-quarter 2025 revenue from subscriptions was $391.4 million (up 5% Y/Y and 3% above Martin&#8217;s estimates), and ad revenue was $22.9 million (down 17% Y/Y and 31% below Martin&#8217;s estimates).
The second-quarter 2025 guidance is for North American (NA) revenue of $340 million-$350 million (down 10% Y/Y at the midpoint), plus rest of world (ROW) revenue of $6.5 million-$7.5 million (down 15% Y/Y at the midpoint), NA subscribers of 1.225 million-1.255 million (down 14% Y/Y at the midpoint), and ROW subscribers of 325K-335K (down 17% Y/Y at the midpoint).
FuboTV subscribers were 1.824 million (-8,000 sequentially) on March 31, down 4% Y/Y and 2% above Martin&#8217;s estimate.
North America reached 1.47 million subscribers (down 206,000 sequentially), down 93% Y/Y and 10% above Martin&#8217;s estimate. North America subscriber ARPU rose 4% Y/Y to $81.25. ROW subscribers declined by 8,000 to 354,000, up 11% Y/Y and 71% above Martin&#8217;s estimate.
FuboTV guided to 1.225 million–1.255 million North American subscribers in the second quarter of 2025 (down 14% Y/Y).
Subscriber guidance reflects churn from Fubo dropping the Univision channels and content and the non-recurrence of Copa America in this year&#8217;s second quarter.
FuboTV reported a substantial gross margin of 16.6%, up >2 times from first-quarter 2024 gross margins of 6.9% and well above Martin&#8217;s estimate of 9.5%. It also improved its adjusted EBITDA loss by $37.4 million Y/Y. The company&#8217;s net income of $188.5 million in the first year of 2025 was better than its reported loss of $56.3 million in the first year of 2024, with the first of 2025 impacted positively by $220 million associated with the gain on litigation settlement. Excluding this impact, the net loss would have been $7.9 million, much better than last year&#8217;s adjusted loss of $34.1 million in the first quarter of 2024.
Free cash flow was a loss of $62 million, up by $9.3 million Y/Y.
FuboTV ad revenue declined by 17% Y/Y in the first quarter of 2025 (31% below Martin&#8217;s estimate), primarily due to the loss of Warner Bros. Discovery, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) and TelevisaUnivision content, which removed MMs of ad units for sale and resulted in Spanish-language bundle disconnects by certain subscribers. Normalized for these, ad revenue would have been up Y/Y.
Martin estimated that FuboTV&#8217;s direct sales force commands a 30%- 50% premium CPM to open-auction, biddable programmatic. Interactive ad formats were up 37% year over year in the first quarter of 2024, and they projected these ads would be up 41% in the first half of 2025.
Martin projected second-quarter revenue of $352.84 million and adjusted EPS of $0.03.
Price Action: Fubo stock traded higher by 0.21% at $2.43 at last check on Monday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/media/25/05/45199354/disney-marvels-thunderbolts-opens-to-162-million-globally" target="_blank" rel="noreferrer noopener">Disney Marvel&#8217;s Thunderbolts Opens To $162 Million Globally</a></li>
</ul>

Comments

Corsair Gaming

Interés en corto

Corsair Gaming (NASDAQ:CRSR) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL